Pfizer (PFE) and its partner BioNTech (BNTX) have infringed a COVID-19 vaccine patent owned by Moderna (MRNA), Reuters reported Wednesday, citing a German court ruling.
The court reportedly ordered Pfizer and BioNTech to disclose earnings related to the patent's use and pay a compensation to Moderna, according to the report.
Pfizer and BioNTech argued they were permitted to use the technology based on Moderna's public statement until the World Health Organization declared in May 2023 that COVID-19 was no longer a global emergency, the media outlet reported.
The court did not determine the compensation amount, which will be decided in further legal proceedings and could change if there is an appeal, Reuters said.
Pfizer, BioNTech and Moderna did not immediately respond to requests for comment from MT Newswires.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 25.87, Change: +0.12, Percent Change: +0.47
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。